🔄 SOP for Handling of Deviations and Change Control

-

🔄 SOP for Handling of Deviations and Change Control

1. Introduction

Deviation management and change control are critical elements of the pharmaceutical quality system. Proper identification, documentation, investigation, and control of deviations and changes ensure continuous improvement, regulatory compliance, and maintenance of product quality, safety, and efficacy.

2. Purpose

To establish a standardized and systematic procedure for identification, documentation, investigation, evaluation, approval, implementation, and closure of deviations and changes in order to maintain compliance with GMP requirements.

3. Scope

This SOP applies to all planned and unplanned deviations and all changes related to facilities, utilities, equipment, processes, systems, documents, materials, and products at the pharmaceutical manufacturing site.

4. Responsibilities

  • All Employees: Identify and immediately report deviations and proposed changes.
  • Department Head: Ensure timely documentation, investigation, and implementation.
  • Quality Assurance (QA): Review, approve, investigate, and close deviations and changes.
  • Cross-functional Team: Perform impact and risk assessment.

5. Definitions

  • Deviation: Departure from an approved SOP, process, specification, or GMP requirement.
  • Planned Deviation: Pre-approved deviation with justification and controls.
  • Unplanned Deviation: Unexpected deviation occurring during operations.
  • Change Control: Formal system to manage changes in a controlled manner.
  • CAPA: Corrective and Preventive Action.

6. Handling of Deviations

6.1 Identification of Deviation

  • Identify any departure from approved procedures or specifications.
  • Immediately inform the supervisor and QA.
  • Segregate affected materials or products if required.

6.2 Documentation of Deviation

  • Initiate deviation report as per approved format.
  • Assign a unique deviation number.
  • Record date, time, location, and detailed description.
  • Classify deviation as minor, major, or critical.

6.3 Deviation Investigation

  • QA shall initiate investigation within defined timelines.
  • Perform root cause analysis using appropriate tools.
  • Identify immediate corrective actions.

6.4 Impact Assessment

  • Assess impact on product quality, safety, and efficacy.
  • Evaluate impact on validated state and regulatory compliance.
  • Document batch disposition recommendation.

6.5 CAPA Implementation

  • Define corrective and preventive actions.
  • Assign responsibility and timelines.
  • QA shall review and approve CAPA.

6.6 Deviation Closure

  • Verify effectiveness of CAPA.
  • QA shall close deviation with justification.
  • Attach all supporting documents.

7. Change Control Procedure

7.1 Initiation of Change

  • Raise change control request with detailed justification.
  • Assign unique change control number.
  • Classify change as minor, major, or critical.

7.2 Risk & Impact Assessment

  • Evaluate impact on quality, validation, safety, and regulatory filings.
  • Perform risk assessment using approved methodology.
  • Identify need for revalidation or regulatory notification.

7.3 Review & Approval

  • QA and cross-functional team shall review change.
  • Approve or reject change before implementation.
  • Document approval with signatures and dates.

7.4 Implementation of Change

  • Implement approved change as per defined plan.
  • Train personnel if required.
  • Update impacted documents and SOPs.

7.5 Verification & Effectiveness Check

  • Verify implementation effectiveness.
  • Review post-change data and performance.
  • Document results.

7.6 Change Closure

  • QA shall close change control after verification.
  • Ensure all documentation is completed.
  • Archive records as per retention policy.

8. Documentation & Record Management

  • Maintain deviation and change control logs.
  • Ensure traceability and data integrity.
  • Make records available during audits.

9. GMP & Regulatory Compliance

  • Follow ALCOA+ data integrity principles.
  • Ensure timely closure of deviations and changes.
  • Trend deviations for continual improvement.

10. References

  • WHO GMP Guidelines
  • EU GMP Chapter 1 – Pharmaceutical Quality System
  • US FDA 21 CFR Part 211
  • ICH Q9 & Q10

© 2025 sopnest.blogspot.com. All rights reserved. This content is independently written and intended for educational purposes. References to regulatory guidelines are for compliance guidance only.

Comments

Post a Comment

Popular posts from this blog

-
⚠️SOP for Risk Management and Risk Assessment (FMEA, RPN, HAZOP, SWOT) This Standard Operating Procedure (SOP) describes a comprehensive risk management and risk assessment framework using FMEA, RPN, HAZOP, and SWOT methodologies. It supports pharmaceutical quality systems in accordance with ICH Q9 and ISO 31000 for effective identification, evaluation, mitigation, and monitoring of risks. 1. Introduction Risk Management is a structured approach to identify, assess, mitigate, and monitor risks in laboratory, R&D, QC, manufacturing, and quality systems. This SOP provides step-by-step instructions for multiple risk assessment techniques, including FMEA, RPN, HAZOP, and SWOT analysis, ensuring robust evaluation, prioritization, and mitigation of risks. 2. Purpose To establish a standardized framework for risk identification, analysis, evaluation, mitigation, monitoring, and continuous improvement using multiple validated risk assessment techniques, ens...
Read more

SOP for Operation and Calibration of UV-Visible Spectrophotometer

-
SOP for UV-Visible Spectrophotometer Operation & Calibration SOP for UV-Visible Spectrophotometer Operation & Calibration SOP Code: [Assign Code] Version: 1.0 Effective Date: [Insert Date] Review Date: [Insert Date] Prepared by: [Name / Designation] Approved by: [Name / Designation] 1. Purpose To provide detailed instructions for safe operation, calibration, and verification of UV-Visible spectrophotometers in compliance with IP, USP, BP, and EP standards to ensure accurate and reliable analytical results. 2. Scope This SOP applies to all analysts and QC personnel performing routine or validation analysis using UV-Visible spectrophotometers. 3. Responsibilities Role Responsibility Analyst / Technician Operate the instrument, prepare standards, perform calibration, and record results. QC / QA Officer Review and approve calibration logs, ensure compliance with pharmacopeial requirements. Maintenance Personnel Perform preventiv...
Read more

Operation and Calibration of Tap Density Apparatus

-
Operation and Calibration of Tap Density Apparatus 1. Purpose To establish a standardized and detailed procedure for the operation, calibration, and maintenance of the Tap Density Apparatus used for determination of bulk density and tapped density of powders, granules, and solid materials in accordance with pharmacopeial and GMP requirements. 2. Scope Quality Control laboratories Research and Development laboratories Production and in-process testing laboratories Any department performing bulk and tap density analysis 3. Definitions Bulk Density: Mass of powder divided by its untapped volume. Tapped Density: Mass of powder divided by the volume after mechanical tapping. Tap Density Apparatus: Instrument that mechanically taps a graduated cylinder to obtain reproducible tapped volume. Carr’s Index: Measure of compressibility calculated from bulk and tapped density. Hausner Ratio: Ratio of tapped density to bulk density. ...
Read more